How Instant NanoBiosensors Hopes Their Technology Will Lead to Early Diagnosis of Neurological Diseases

Instant NanoBiosensors (INB) is an innovative technology company which has developed next generation, ultra sensitive digital immunoassay platforms that may advance precision health care for life sciences research and diagnostics. The platform, named Ultra-sensitive Light Sensing Biomarker Analyzer, is based on patented FOPPR (Fiber Optic Particle Plasmon Resonance) and IN-Chip (Auto-flowing microfluidic chip) technology for life science research and in vitro diagnostics (IVD) markets. It enables customers to reliably detect protein biomarkers in extremely low concentrations in blood, serum, and other fluids that, in many cases, are undetectable using conventional, analog immunoassay technologies. It also allows researchers to validate the functions of novel protein biomarkers that are only present in very low concentrations and have been discovered using technologies such as mass spectrometry.

Exhibitor Data Sheet